Kidney Transplantation
📧 Sign up to get email alerts when something new happens for Kidney Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-17Clinical Trial Update: Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation [Phase 4]
Phase 4 study evaluating whether the ratio of total tacrolimus dose to trough level with Envarsus affects renal function (eGFR) in kidney tr…
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Comparison of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients [Phase 4]
Phase 4 trial comparing tacrolimus extended-release (Envarsus XR) to immediate-release tacrolimus in HLA-sensitized kidney transplant recipi…
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: FIH Phase I/IIa Trial Evaluating Safety of TUM012 to Minimize Ischemic Reperfusion Injury in Kidney Transplantation [Phase 1, Phase 2]
An early-phase (Phase I/IIa) clinical trial evaluating the safety of TUM012 to minimize ischemia-reperfusion injury in kidney transplantatio…
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: Quantify the Benefits of Biomarkers in Routine Patient Care in Kidney Transplant Recipients [NA]
A completed clinical trial update evaluates the benefits of using biomarkers in routine care for kidney transplant recipients. The study aim…
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: Impact of HLA Evolutionary Divergence and HLA Donor-recipient Molecular Mismatches on Kidney Allograft Rejection
A completed clinical trial evaluates whether HLA evolutionary divergence and donor–recipient molecular mismatches influence kidney allograft…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome [Phase 4]
Phase 4 clinical trial update evaluating the impact of lymphocyte anti-metabolite immunosuppressants on donor-specific anti-HLA antibodies a…
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus [Phase 4]
Phase 4 trial update evaluating pharmacokinetics of switching from twice-daily tacrolimus to once-daily extended-release tacrolimus in diabe…
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant Patients [Phase 4]
Phase 4 trial comparing standard-dose versus reduced-dose tacrolimus with sirolimus in renal transplant patients has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With Sirolimus [Phase 4]
Phase 4 trial comparing reduced versus standard dose cyclosporine with sirolimus in kidney transplant patients assessing graft function; com…
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients (TRAINING) [Phase 4]
Clinical trial update for a Phase 4 study evaluating treatment of early borderline lesions in low immunological risk kidney transplant patie…
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: A Study of CMV Vaccine (HB-101) in Kidney Transplant Patients [Phase 2]
Phase 2 trial evaluating CMV vaccine HB-101 in kidney transplant patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant [Phase 2]
Phase 2 trial evaluating safety and efficacy of dual costimulation blockade with VIB4920 and belatacept to prevent allograft rejection in ad…
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Tacrolimus/Sirolimus Versus Tacrolimus/Mycophenolate Mofetil (MMF) Versus Neoral/Sirolimus in Adult, Primary Kidney Transplantation [Phase 4]
Phase 4 clinical trial comparing tacrolimus/sirolimus, tacrolimus/mycophenolate mofetil (MMF), and Neoral/sirolimus in adult primary kidney …
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Living Donor Renal Transplantation [Phase 4]
Phase 4 trial comparing Thymoglobulin, Campath-1H, and Daclizumab in adult living-donor kidney transplantation.
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Utilization of Hepatitis C Positive Kidneys in Negative Recipients [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating the use of hepatitis C positive donor kidneys transplanted into hepatitis C negative recipients; study c…
-
CLINICAL_TRIALS trial_result · 2023-09-05Clinical Trial Update: Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies [Phase 3]
Phase 3 clinical trial evaluating induction therapy in sensitized kidney transplant recipients without pre-existing donor-specific antibodie…
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients [Phase 2, Phase 3]
Phase 2/3 trial updates on sitafloxacin and ertapenem for acute urinary tract infections due to E. coli or Klebsiella in post-kidney transpl…
-
CLINICAL_TRIALS trial_result · 2023-01-09Clinical Trial Update: CAMPath and BELimumab for Transplant Tolerance in Sensitized Kidney Transplant Recipients [Phase 2]
Phase 2 trial update for CAMPath and belimumab in sensitized kidney transplant recipients was terminated; results published in 2023.
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: The Safety, Completion Rate and Prevention Effect by Rifamycin-containing Regimens for Latent Tuberculosis Infection in Patients With Kidney Transplantation: a Prospective Intervention Pilot Study [Phase 4]
A Phase 4 prospective pilot study evaluating rifamycin-containing regimens for latent tuberculosis infection in kidney transplant patients, …
-
CLINICAL_TRIALS trial_result · 2022-07-21Clinical Trial Update: Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant Recipients [Phase 4]
Phase 4 trial investigating pharmacogenomic-guided tacrolimus dosing and monitoring in kidney transplant recipients has completed with resul…
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: Preserve-Transplant Study [Phase 4]
Phase 4 clinical trial update for the Preserve-Transplant study completed.
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation [Phase 2]
Phase 2 trial comparing valganciclovir to valacyclovir for viral prophylaxis in kidney transplantation; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen [Phase 4]
Phase 4 clinical trial comparing steroid-free immunosuppression or calcineurin inhibitor minimization after basiliximab induction with a sta…
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis [Phase 4]
Phase 4 trial comparing 3g vs 2g mycophenolate mofetil (MMF) with tacrolimus in renal allograft fibrosis progression; completed study.
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal Transplantation [Phase 4]
A Phase 4 trial comparing Campath-Tacrolimus vs IL2R monoclonal antibody/Tacrolimus/MMF in renal transplantation has completed with posted r…